我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Review on Pathology of Dementia after TBI

Rahman Farheen

Despite the growing body of evidence indicating an increased risk of DAT following a TBI, the specific underlying pathology responsible for this risk remains a mystery. The majority of mechanistic explanations focus on a presumption of a neuropathologic trigger that is activated at the time of the injury and continues to evolve over time, eventually leading to dementia [1]. Axonal damage is a hallmark of both traumatic brain injury (TBI) and Alzheimer’s disease (AD), so many have looked into this possibility as a link between TBI and dementia. Amyloid-b (Ab), the primary protein most frequently associated with AD, has been shown to accumulate within neuronal cell bodies and injured axons within hours to days of TBI, according to human and animal models [2]. Amyloid precursor protein (APP) expression rises in injured axons and neuronal cell bodies in response to trauma, resulting in an increase in Ab production. It is hypothesized that this accumulation of APP and Ab plays a significant role in the subsequent Ab plaque formation, which is one of the hallmarks of AD. Additionally, it is hypothesized that the APOE 4 genotype may influence amyloid pathology and TBI outcome, putting individuals with this allele at increased risk for AD